Annual Statements Open main menu

AMERITYRE CORP - Quarter Report: 2019 December (Form 10-Q)

amerityre20191231_10q.htm

 



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 


 

FORM 10-Q

 


 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended:   December 31, 2019

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________________ to ____________________.

 

Commission file number: 000-50053

AMERITYRE CORPORATION

(Exact name of small business issuer as specified in its charter)

 

NEVADA

87-0535207

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

 

1501 INDUSTRIAL ROAD, BOULDER CITY, NEVADA

89005

(Address of principal executive offices)

(Zip Code)

 

(702) 293-1930

(Issuer’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒   No ☐

  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒   No ☐

 

Indicate by check mark whether the registrant is large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” accelerated filer” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer  ☐      Accelerated filer  ☐      Non-accelerated filer  ☒      Smaller reporting company ☒        Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ☐   No  ☒

 

The number of shares outstanding of Registrant’s Common Stock as of February 14, 2020: 48,922,868 

  

 

 

 

 

TABLE OF CONTENTS

 

 

 

Page

PART I

Item 1.

Financial Statements

3

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operation

11

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

18

Item 4.

Controls and Procedures

18

PART II

Item 1.

Legal Proceedings

19

Item 1A.

Risk Factors

19

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

19

Item 3.

Defaults Upon Senior Securities

19

Item 4.

Mine Safety Disclosures

19

Item 5.

Other Information

19

Item 6.

Exhibits

19

 

 

 

SIGNATURES

20

 

 

 

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1.  FINANCIAL STATEMENTS

AMERITYRE CORPORATION

Balance Sheets

   

December 31,

2019

   

June 30,

2019

 
   

(Unaudited)

         

ASSETS

               

CURRENT ASSETS

               

Cash

  $ 340,062     $ 557,026  

Accounts receivable

    317,323       277,690  

Inventory - net

    512,919       448,407  

Prepaid and other current assets

    111,419       82,596  

Total Current Assets

    1,281,723       1,365,719  
                 

RIGHT TO USE LEASE ASSETS, OPERATING, NET

    768,632       845,256  
                 

PROPERTY AND EQUIPMENT

               

Molds and models

    583,611       583,611  

Equipment

    3,026,865       3,003,797  

Furniture and fixtures

    73,423       66,173  

Software

    247,610       247,610  

Less - accumulated depreciation

    (3,798,961

)

    (3,763,672

)

Total Property and Equipment - net

    132,548       137,519  
                 

OTHER ASSETS

               

Patents and trademarks - net

    101,753       110,601  

Non-current inventory

    317,018       269,824  

Deposits

    11,000       11,000  

Total Other Assets

    429,771       391,425  

TOTAL ASSETS

  $ 2,612,674     $ 2,739,919  
                 

LIABILITIES AND STOCKHOLDERS’ EQUITY

               

CURRENT LIABILITIES

               

Accounts payable and accrued expenses

  $ 599,878     $ 649,046  

Current portion of long-term debt

    2,000       13,609  

Current portion of lease liability

    143,400       141,000  

Deferred revenue

    -       19,408  

Total Current Liabilities

    745,278       823,063  
                 

Long-term debt, net of current portion

    61,906       75,418  

Long-term lease liability

    521,100       594,000  

TOTAL LIABILITIES

    1,328,284       1,492,481  
                 

STOCKHOLDERS’ EQUITY

               

Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively

    2,000       2,000  

Common Stock: 75,000,000 shares authorized of $0.001 par value, 48,922,868 and 47,727,867 shares issued and outstanding, respectively

    48,923       47,728  

Additional paid-in capital

    62,714,077       62,695,035  

Stock payable

    -       583  

Accumulated deficit

    (61,480,610

)

    (61,497,908

)

Total Stockholders’ Equity

    1,284,390       1,247,438  

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

  $ 2,612,674     $ 2,739,919  

 

The accompanying notes are an integral part of these financial statements.

 

 

AMERITYRE CORPORATION

Statements of Operations

(Unaudited)

 

   

For the Three Months Ended

December 31,

   

For the Six Months Ended

December 31,

 
   

2019

   

2018

   

2019

   

2018

 
                                 

NET SALES

  $ 1,067,440     $ 785,105     $ 2,046,737     $ 1,612,349  
                                 

COST OF GOODS SOLD

    768,758       637,265       1,459,357       1,198,277  
                                 

GROSS PROFIT

    298,682       147,840       587,380       414,072  
                                 

EXPENSES

                               

Research and development

    35,897       24,717       61,913       47,790  

Sales and marketing

    51,309       53,325       94,780       104,249  

General and administrative

    172,936       163,895       366,366       353,443  
                                 

Total Expenses

    260,142       241,937       523,059       505,482  
                                 

INCOME/(LOSS) FROM OPERATIONS

    38,540       (94,097

)

    64,321       (91,410

)

                                 

OTHER INCOME/(EXPENSE)

                               

Interest expense

    (103

)

    (776

)

    (438

)

    (2,338

)

Interest income

    119       129       293       232  

Other income

    (161 )     -       3,122       3,089  

Total Other Income/(Expense), net

    (145

)

    (647

)

    2,977       983  
                                 

NET INCOME/(LOSS)

    38,395       (94,744

)

    67,298       (90,427

)

                                 

Preferred Stock Dividend

    (25,000

)

    (25,000

)

    (50,000

)

    (50,000

)

                                 

NET INCOME/(LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS

  $ 13,395     $ (119,744

)

  $ 17,298     $ (140,427

)

                                 

BASIC AND DILUTED INCOME/(LOSS) PER SHARE

  $ 0.00     $ (0.00

)

  $ 0.00     $ (0.00

)

                                 

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING

    48,260,422       45,886,695       47,994,144       45,200,365  

 

The accompanying notes are an integral part of these financial statements.

 

 

AMERITYRE CORPORATION

Statements of Stockholders’ Equity

(Unaudited)

 

   

Preferred Stock

   

Common Stock

   

Additional

Paid in

   

Stock

   

Accumulated

 
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Payable

   

Deficit

 

Balance, June 30, 2018

    2,000,000     $ 2,000       44,476,346     $ 44,476     $ 62,638,754     $ 14,601     $ (61,438,920

)

Preferred stock dividends

    -       -       -       -       -       -       (25,000

)

Stock option based compensation expense – options

    -       -       -       -       2,901       -       -  

Stock based compensation expense for employee and Board of Director service

    -       -       1,155,796       1,156       18,035       (4,806

)

    -  

Net income for the quarter

    -       -       -       -       -       -       4,317  

Balance, September 30, 2018

    2,000,000       2,000       45,632,142       45,632       62,659,690       9,795       (61,459,603

)

Preferred stock dividends

    -       -       -       -       -       -       (25,000

)

Stock option based compensation expense – options

    -       -       -       -       967       -       -  

Stock based compensation expense for employee and Board of Director service

    -       -       900,725       901       15,336       (9,212

)

    -  

Net loss for the quarter

    -       -       -       -       -       -       (94,744

)

Balance, December 31, 2018

    2,000,000       2,000       46,532,867       46,533       62,675,993       583       (61,579,347

)

Preferred stock dividends

    -       -       -       -       -       -       (25,000

)

Stock based compensation expense for employee and Board of Director service

    -       -       -       -       -       10,119       -  

Net income for the quarter

    -       -       -       -       -       -       69,879  

Balance, March 31, 2019

    2,000,000       2,000       46,532,867       46,533       62,675,993       10,702       (61,534,468

)

Preferred stock dividends

    -       -       -       -       -       -       (25,000

)

Stock based compensation expense for employee and Board of Director service

    -       -       1,195,000       1,195       19,042       (10,118

)

    -  

Net income for the quarter

    -       -       -       -       -       -       61,560  

Balance, June 30, 2019

    2,000,000       2,000       47,727,867       47,728       62,695,035       583       (61,497,908

)

Preferred stock dividends

    -       -       -       -       -       -       (25,000

)

Stock based compensation expense for employee and Board of Director service

    -       -       -       -       -       10,119       -  

Net income for the quarter

    -       -       -       -       -       -       28,903  

Balance, September 30, 2019

    2,000,000       2,000       47,727,867       47,728       62,695,035       10,702       (61,494,005

)

Preferred stock dividends

    -       -       -       -       -       -       (25,000

)

Stock based compensation expense for employee and Board of Director service

    -       -       1,195,001       1,195       19,042       (10,702

)

    -  

Net income for the quarter

    -       -       -       -       -       -       38,395  

Balance, December 31, 2019

    2,000,000     $ 2,000       48,922,868     $ 48,923     $ 62,714,077     $ -     $ (61,480,610

)

 

The accompanying notes are an integral part of these financial statements.

 

 

AMERITYRE CORPORATION

Statements of Cash Flows

(Unaudited)

 

   

For the Six Months Ended

December 31,

 
   

2019

   

2018

 

CASH FLOWS FROM OPERATING ACTIVITIES

               

Net income/(loss)

  $ 67,298     $ (90,427

)

Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:

               

Depreciation and amortization expense

    120,762       41,221  

Stock based compensation

    19,654       17,778  

Changes in operating assets and liabilities:

               

Accounts receivable

    (39,633

)

    133,787  

Inventory and inventory reserve

    (111,706

)

    9,499  

Prepaid and other current assets

    (28,823

)

    (32,669

)

Accounts payable and accrued expenses

    (99,169

)

    96,819  

Deferred revenue

    (19,408

)

    (6,794

)

Lease liability payable, operating lease

    (70,500

)

    -  

Net Cash Provided (Used) by Operating Activities

    (161,525

)

    169,214  

CASH FLOWS USED IN INVESTING ACTIVITIES

               

Purchase of property and equipment

    (30,318

)

    (78,302

)

CASH FLOWS USED IN FINANCING ACTIVITIES

               

Payments on notes payable

    (25,121

)

    (9,335

)

                 

NET INCREASE (DECREASE) IN CASH

    (216,964

)

    81,577  
                 

CASH AT BEGINNING OF PERIOD

    557,026       213,854  

CASH AT END OF PERIOD

  $ 340,062     $ 295,431  

 

SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES

               
                 

Interest paid

  $ 776     $ 2,338  

Income taxes paid

  $ -     $ -  
                 

NON-CASH INVESTING AND FINANCING ACTIVITIES

               
                 

Accrued preferred stock dividends

  $ 50,000     $ 50,000  

Issuance of common stock previously accrued for

  $ 583     $ 35,427  

 

The accompanying notes are an integral part of these financial statements.

 

 

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

December 31, 2019

 

NOTE 1 – BASIS OF FINANCIAL STATEMENT PRESENTATION

 

The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2019 (the “2019 Annual Report”).  Operating results for the fiscal quarter ended December 31, 2019 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2020.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our 2019 Annual Report, except as noted below.

 

Revenue Recognition

 

The majority of our revenue is derived from short-term sales contracts. We account for revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers”.

 

Revenue for our products is recognized at the time in which our performance obligation is satisfied which we have defined as “control” of the product by the customer. “Control” is defined as a customer having “rights/obligations of physical control over the product or has the rights and intention to control the product.” Based on the terms of our contracts, a customer’s “control” is based on analysis of the following; (i) when a customer arranges shipment of product themselves, and once the product has left our dock, Amerityre Corporation (the “Company” or “Amerityre”), recognizes revenue for the product.  In effect by arranging their own freight, the customer is “taking control” of the product when it leaves our warehouse; or (ii) when a customer does not arrange shipment of product themselves, we cannot recognize revenue until it is delivered and the customer takes “control” of the product. This establishes a “deferred revenue” event until such time as delivery of the product has been completed and we have proof from the shipper of the delivery (and change in control).

 

As of December 31, 2019, we had no deferred revenue.  Deferred revenue was $13,917 inclusive of $739 of shipping and handling revenue as of December 31, 2018.

 

Shipping and Handling

 

Shipping and Handling Fees require that freight costs charged to customers be classified as revenues. Freight expenses are included in costs of sales and are recognized as incurred.  Due to our adoption of ASC 606 as discussed above, we defer the revenues of shipping and handling until the related revenue is also recognized.

 

At December 31, 2019 we had no deferred shipping and handling versus December 31, 2018 which $739.

 

Right to Use Assets – Leases

 

We account for all Company leases following a multi-step analysis process which includes:

 

 

Analysis of all agreements to determine if a lease exists, inclusive of this analysis is the length of the agreement and amount of the resulting liability. Based on this we have determined the following:

 

Assets with a length less than one year are not considered leases and,

 

Assets with a value of less than our capitalization policy of $2,500 are not considered a lease.

 

 

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

December 31, 2019

 

Items that do not qualify as leases are treated similar to service agreements and expensed as incurred.

 

Once an item qualifies for lease accounting, we analyze the item for operating or finance lease treatment with the major difference that finance leases include interest as a term note would. In the case that a finance lease does not have a stated interest rate, we will impute the interest.

 

Both operating and finance leases result in a right to use asset and related lease liability on our balance sheet.

 

Items that enhance a lease asset, such as leasehold improvements, are capitalized with the related right to use such asset. Amortization of that improvement is based on all known facts inclusive of the lease term. 

 

Reclassifications

 

Certain reclassifications have been made to these financial statements which have no impact in the quarter to date or year to date net income of the Company. During the preparation of these filings, the Company noted that our presentation of our payments toward, and the related amortization of, our right to use leased assets were reflected as a non-cash transaction for the three months ended September 30, 2019. We have corrected this presentation to reflect the payments toward our lease liability as a cash outflow in operating activities and the related amortization of our right to use leased assets as part of our depreciation and amortization line item, also in operating activities. The overall result is both an increase and decrease to specific line items within operating activities, but does not affect the end result of operating activities.

 

Additionally, leasehold improvements amortization costs are now reported through all departments instead of solely to general and administration departments. This reclassification was made in order to better reflect the benefit of these expenses.

 

Basic and Fully Diluted Net Income (Loss) Per Share

 

Basic and Fully Diluted net income (loss) per share is computed using the weighted-average number of common shares outstanding during the period.

 

Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation.  We excluded 2,870,000 and 6,300,000 common stock equivalents for the periods ended December 31, 2019 and 2018, respectively, because they are anti-dilutive.

 

Recent Accounting Pronouncements

 

Other recent accounting pronouncements issued by the Financial Accounting Standards Board (“FASB”) (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.

  

NOTE 3 – INVENTORY

 

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.

 

   

December 31, 2019

   

June 30, 2019

 
   

(Unaudited)

         

Raw Materials

  $ 272,337     $ 221,767  

Finished Goods

    628,827       557,977  

Inventory reserve

    (71,227

)

    (61,513

)

Inventory - net

  $ 829,937       718,231  

 

Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.

 

The Company critically reviews all slow-moving inventory to determine if it is defective or obsolete.  If not defective or obsolete we presented these items as non-current inventory, although all inventory is ready and available for sale at any moment.  

 

 

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

December 31, 2019

 

NOTE 4 – RIGHT TO USE LEASE ASSETS

 

Based on our lease accounting policy, we have identified the following operating leases. As of December 31, 2019, we have no financing leases:

 

   

December 31, 2019

   

June 30, 2019

 
   

(Unaudited)

         

Facility lease

  $ 664,500     $ 735,000  

Leasehold improvements related to our facility

    280,377       280,376  

Accumulated amortization – leasehold improvements

    (176,245 )     (170,120

)

Right to use leased assets, operating, net

  $ 768,632     $ 845,256  

 

In March 2019 we negotiated a five year extension of the lease for our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada.  The property consists of a 49,200 square foot building.  We currently occupy all 49,200 square feet, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres.  Our remaining liability under this agreement is $664,500, payable at amounts ranging from $11,750 to $12,600 a month until June 30, 2024.

 

NOTE 5 – DEBT

 

A former board member, Silas O. Kines, was the principal owner of Forklift Tire of Florida and K-2 Industrial Tire, Inc.  In accordance with the Commission Agreement with Forklift Tire of Florida, dated February 2, 2011, between Amerityre Corporation and K-2 Industrial Tire, Inc., K-2 is due a five percent (5%) commission on all forklift tire sales.  In exchange for the forklift models transferred to Amerityre under that agreement, the first $96,000 in commission payments will be used to extinguish the long-term liability recorded on the transaction.  As of December 31, 2019, $2,000 and $61,906 (June 30, 2019, $2,000 and $62,089) were recorded for the current and long-term portion, respectively, of the related liability.

 

In June 2016, the Company executed a term note with U.S. Bank to finance critical manufacturing equipment and operating enhancements.  The total amount financed was $55,068, at 5.59% interest, with payments of $1,059 due for 60 months starting July 2016. This note was paid in full in October 2019. 

 

NOTE 6 – STOCK OPTIONS AND WARRANTS

 

Prior Issuances of options

 

On January 1, 2018, 480,000 options were granted to the Company’s Chief Executive Officer as part of his employment offer.  The options have a strike price of $0.10, vest ratably January 1, 2018 to December 31, 2018 and expire December 31, 2021.  We estimated the fair value of the stock options above at the grant date based on the following weighted average assumptions:

 

Risk-free interest rate

    2.010

%

Expected life

    3.0  years

Expected volatility

    114.38

%

Dividend yield

    0.00

%

 

A summary of the status of our outstanding stock options as of December 31, 2019 and June 30, 2019 and changes during the periods then ended is presented below:

 

   

December 31, 2019

   

June 30, 2019

 
           

Weight Average

   

Intrinsic

           

Weight Average

   

Intrinsic

 
   

Shares

   

Exercise Price

   

Value

   

Shares

   

Exercise Price

   

Value

 

Outstanding beginning of period

    3,970,000     $ 0.12               3,730,000     $ 0.13          

Granted

    -     $ 0.00               480,000     $ 0.10          

Expired/Cancelled

    (1,100,000

)

  $ (0.14

)

            (240,000

)

  $ (0.10

)

       

Exercised

    -     $ 0.00               -     $ 0.00          

Outstanding end of period

    2,870,000     $ 0.12     $ -       3,970,000     $ 0.12     $ -  

Exercisable

    2,870,000     $ 0.12     $ -       3,970,000     $ 0.12     $ -  

 

 

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

December 31, 2019

 

The following table summarizes the range of outstanding and exercisable options as of December 31, 2019:

 

       

Outstanding

   

Exercisable

 

Range of

Exercise Prices

   

Number Outstanding

at

December 31, 2019

   

Weighted

Average

Remaining

Contractual Life

   

Weighted

Average

Exercise Price

   

Number

Exercisable at

December 31, 2019

   

Weighted

Average Remaining

Contractual Life

 
$ 0.08       150,000       1.92     $ 0.08       150,000       1.92  
$ 0.10       1,920,000       1.19     $ 0.10       1,920,000       1.19  
$ 0.17       800,000       1.42     $ 0.17       800,000       1.42  
          2,870,000                       2,870,000          

 

NOTE 7 – STOCK TRANSACTIONS

 

After an analysis of the above stock options expiration and in association with the Company’s desire to retain its Chief Executive Officer, the Board of Directors approved the termination of the 2017 Omnibus Stock Option and Award Plan on December 4, 2019. Any stock instrument available but unencumbered under this plan was also released.

 

On December 4, 2019, the Board of Directors adopted the 2019 Equity Incentive Plan which contains provisions for up to 2,500,000 stock-based instruments to be granted to employees, consultants and directors.

 

On December 18, 2019, the Company renewed the Chief Executive Officer’s Employment Agreement.  The new Agreement extends his term of employment to December 31, 2020.  Inclusive in this new Agreement is a stock award of 1.98 million shares of the Company’s common stock vesting ratably over 12 months (January 2020 – December 2020), valued at a fixed rate of $0.0192, the average price per share of the Company’s common stock for the period December 24, 2019 to December 31, 2019. 

 

NOTE 8 – SUBSEQUENT EVENTS

 

On January 22, 2020, 60,000 shares of common stock were granted to the Company’s Chief Financial Officer as part of her employment renewal.  The shares are valued as of January 21, 2020 and vest ratably on a quarterly basis through December 2020.  No additional changes were made to her compensation on renewal of her employment.

 

On January 22, 2020, the Board of Directors unanimously approved the Company to enter into a banking relationship with Lexicon Bank which includes the negotiation of a $50,000 revolving line of credit. As of the date of this filing, terms on the line of credit are being finalized.

 

On January 24, 2020, 460,000 shares of common stock were granted to the Company’s Board members as compensation for the term ending November 2020.  Each non-executive Board member receives 93,750 shares, with the Audit Committee Chair receiving 156,250 shares and the Compensation Committee Chair receiving 116,250 shares.  The shares vest ratably on a monthly basis over the January 2020 – November 2020 period. The shares are valued at $0.02, the closing price per share of our common stock on January 24, 2020. 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis contain forward-looking statements relating to future events or our future financial performance or financial condition.  Such statements are only predictions and the actual events or results may differ materially from the results discussed in or implied by the forward-looking statements.  Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the Risk Factors contained in our 2019 Annual Report as well as those discussed elsewhere in this report.  The historical results set forth in this discussion and analysis are not necessarily indicative of trends with respect to any actual or projected future financial performance.  This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.

 

Overview

 

Amerityre engages in the research and development, manufacturing, and sale of solid polyurethane foam tires.  We have developed unique polyurethane formulations that allow us to make products with superior performance characteristics in the areas of abrasion resistance, energy efficiency and load-bearing capabilities, when compared to conventional rubber tires.  We also believe that our manufacturing processes are more energy efficient than the traditional, rubber tire, manufacturing processes, in part because our polyurethane compounds do not require the multiple processing steps, extreme heat, and high pressure that are necessary to cure rubber. We believe tires produced with our proprietary polyurethane formulations last longer, are less susceptible to failure and are friendlier to the environment when compared to competitor offerings.

 

We concentrate on three segments of the flat free tire market:  light duty polyurethane foam tires, polyurethane elastomer industrial tires and agricultural tires. Our focus continues to be applications and markets where our advantages in product technology, tire performance, and customer service give us an opportunity to obtain premium pricing. Our most recent activities in these areas are set forth below:

 

Light Duty Polyurethane Foam Tires – The sale of polyurethane foam tires to original equipment manufacturers, distributors and dealers accounts for the majority of our revenue. We produce a broad range of products for the light duty tire market. Our product development and marketing efforts are focused on building customer relationships and expanding sales with original equipment manufacturers and tire distributors.  Our competitive advantage is creating unique product solutions for customers who have challenging tire performance requirements that cannot be met by competitor offerings.

 

We continued to experience strong demand for our polyurethane foam tires in the fiscal 2020 second quarter, exceeding our expectations. Higher sales were driven by stability in the overall economy as well as seasonal factors that have traditionally boosted sales this time of year. While the tariff dispute with China continues to provide a headwind to our imported wheel rim costs and the overall US economy. For the majority of our products we continue to manage these costs with minimal price increases to our customers. We reluctantly implemented a small price increase on our industrial wheel assemblies to partially offset price increases on purchased 12 inch rims during the first quarter of fiscal year 2020.

 

Polyurethane Elastomer Industrial Tires – We had negligible sales of elastomer forklift and elastomer industrial tires during the fiscal 2020 second quarter. During the recent quarter we produced additional elastomer samples for new customer projects currently under evaluation. Once the testing of these samples is complete we expect to be able to evaluate whether this development will lead to new business in the coming quarters. 

 

The Company continued to see increasing sales of tires produced with its new elastomer formulation ElastothaneTM 500. Sales to date are mainly small orders from customers conducting tire evaluations. We remain optimistic that this new formulation represents a significant business opportunity as product adoption increases.

 

Agricultural Tires – Agricultural tires sales continue to remain under pressure due to international trade issues and low farm incomes. The lifting of Chinese tariffs on US-grown soybeans and certain other agricultural products should remove some of the drag on commodity pricing domestically and on overseas demand. We have ongoing discussions with original equipment manufacturers (OEMs) and distributors to identify new opportunities for our elastomer products. The introduction of our ElastothaneTM 500 formulation has generated new interest in our tire offerings for agricultural applications, which we believe will present new business opportunities once the farmers have money to invest in new equipment.

 

Due to the Company’s limited resources, business development projects which require significant investment have been put on hold. We believe investment in new and improved products is important to the continued growth of our business, and we will continue to selectively invest in promising opportunities that fit our current financial plan. We have several ongoing product evaluation programs that have the potential to develop into significant business in the coming quarters.

 

 

As described above, our product line covers a wide range of diverse market segments which are unrelated in terms of customer base, product distribution, market demands and competition. Our external sales team is comprised of independent manufacturer representatives with strong tire industry experience.  The Company’s strategy of targeted marketing campaigns and proper product pricing continue to drive more profitable sales.  Our website is a valuable educational tool for the marketplace, and it continues to generate some online sales. During the recent quarter we also launched our Amazon store for online sale of golf cart and industrial tire assemblies.

 

Our strategy continues to be based on focusing resources on the development of market segments where we have identified technological and product performance advantages. Costs for raw materials remained stable during the fiscal second quarter of 2020, versus the fiscal first quarter of 2020, as the trade dispute and tariffs between China and the US did not escalate during the period, although tariff relief on our wheel rims imported from China has not yet been obtained. Improving top line sales revenue growth remains our primary goal, and sales for the second quarter of fiscal 2020 were 35.9% higher than the second quarter of fiscal 2019. Our ability to broaden our customer base has enabled us to overcome challenging business conditions in key segments, and we are optimistic that these new customers will develop into larger revenue opportunities as applications for our tires continues to grow. Continued strength in the US economy remains a key factor in our future revenue growth expectations, and weakness in the overall economy remains a risk factor in the latter half of fiscal year 2020.

 

Factors Affecting Results of Operations

 

Our operating expenses consisted primarily of the following:

 

 

Cost of sales, which consists primarily of raw materials, components and production costs of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

 

 

Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;

 

 

Research and development expenses, which consist primarily of direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;

 

 

• 

Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;

 

 

•  

Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

 

 

• 

Stock based compensation expense related to stock and stock option awards issued to employees and consultants for services performed for the Company.

 

Critical Accounting Policies

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with United States generally accepted accounting principles.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses.  On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies.  We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances.  These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

We believe the following accounting policies are our critical accounting policies because they are important to the portrayal of our financial condition and results of operations and they require critical management judgments and estimates about matters that may be uncertain.  If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.

 

Valuation of Intangible Assets and Goodwill

 

Patent and trademark costs have been capitalized at December 31, 2019, totaling $487,633 with accumulated amortization of $385,880 for a net book value of $101,753. Patent and trademark costs capitalized at December 31, 2018, totaled $487,633 with accumulated amortization of $366,457 for a net book value of $121,176.

 

 

The patents which have been granted are being amortized over a period of 20 years. Patents which are pending or are being developed are not amortized. Amortization begins once the patents have been issued. As of December 31, 2019, and 2018, respectively, there were no pending patents.  Annually, pending or expired patents are inventoried and analyzed, which resulted in the recognition of a loss on abandonment, expiration or retirement of patents and trademarks of $-0- for each of the three and six month periods ended December 31, 2019 and 2018, respectively.

 

Amortization expense for the years ended December 31, 2019 and 2018 was $8,849 and $11,429 respectively.  The Company evaluates the recoverability of intangibles and reviews the amortization period on a continual basis utilizing the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350, Intangibles – Goodwill and Other.  We consider the following indicators, among others, when determining whether or not our patents are impaired:

 

 

any changes in the market relating to the patents that would decrease the life of the asset;

 

 

any adverse change in the extent or manner in which the patents are being used;

 

 

any significant adverse change in legal factors relating to the use of the patents;

 

 

current period operating or cash flow loss combined with our history of operating or cash flow losses;

 

 

future cash flow values based on the expectation of commercialization through licensing; and

 

 

current expectations that, more likely than not, the patents will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.

 

Results of Operations

 

Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our sales and cash flows.  These key performance indicators include:

 

 

•  

Revenues, net of returns and trade discounts, which consists of product sales and services and is an indicator of our overall business growth and the success of our sales and marketing efforts;

 

 

•  

Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;

 

 

•  

Growth in our customer base, which is an indicator of the success of our sales efforts; and

 

 

•  

Distribution of sales across our products offered.

 

The following summary table presents a comparison of our results of operations for the fiscal quarters ended December 31, 2019 and 2018 with respect to certain key financial measures.  The comparisons illustrated in the table are discussed in greater detail below. 

 

   

For the Three Months Ended

December 31,

           

For the Six Months Ended

December 31

         
   

(in 000’s)

   

Change

   

(in 000’s)

   

Change

 
   

2019

   

2018

   

2019 vs. 2018

   

2019

   

2018

   

2019 vs. 2018

 

Net revenues

  $ 1,067     $ 785       35.9

%

  $ 2,047     $ 1,612       27.0

%

Cost of revenues

    (768

)

    (637

)

    20.6

%

    (1,460

)

    (1,198

)

    21.9

%

Gross profit

    299       148       102.0

%

    587       414       41.8

%

Research & Development

    (36

)

    (25

)

    44.0

%

    (62

)

    (48

)

    29.2

%

Sales and Marketing

    (51

)

    (53

)

    (3.8

%)

    (95

)

    (104

)

    (8.7

%)

General and Administrative

    (174

)

    (164

)

    6.1

%

    (366

)

    (353

)

    3.4

%

Other income (expense)

    -       (1

)

    (100.

%)

    3       1       200.0

%

Net income (loss)

    38       (95

)

    (140.0

%)

    67       (90

)

    (174.4

%)

Preferred stock dividend

    (25

)

    (25

)

    0.00

%

    (50

)

    (50

)

    0.0

%

Net income (loss) attributable to common shareholders

  $ 13     $ (120

)

    (110.8

%)

  $ 17     $ (140

)

    (112.1

%)

 

 

Quarter Ended December 31, 2019 Compared to December 31, 2018

 

Net Revenues.  Net revenues of $1,067,440 for the quarter ended December 31, 2019, represents a 35.9% increase over net revenues of $785,105 for the same period in 2018. These results exceeded our expectations. The improved results were driven by higher than expected polyurethane foam tires from current customers as well as purchases from new customers. We expect our polyurethane foam products to continue to account for the majority of our sales during the upcoming fiscal year.

 

Cost of Revenues.  Cost of revenues for the quarter ended December 31, 2019 was $768,758 or 72.0% of sales compared to $637,265 or 81.2% of sales for the same period in 2018. This increase in Gross Margin was due to sales of higher margin products in the recent quarter compared to the year earlier period. There was also a stabilization in the costs associated with chemical raw material and steel wheels. We anticipate that raw material costs volatility will remain stable for the rest of fiscal year 2020, with no additional costs associated with trade tariffs.  

 

Gross Profit.  Gross profit for the quarter ended December 31, 2019 was $298,682 compared to $147,840 for the same period in 2018. Gross profit for the quarter ended December 31, 2019 increased by $150,842 or 102.0% over the same period in 2018 due to greater sales of higher margin products.  The December 31, 2019 gross profit reflects a 28.0% gross margin for product sales compared to a gross margin on product sales of 18.8% in 2018.

 

Research & Development Expenses (R&D).  Research and development expenses for the quarter ended December 31, 2019 were $35,897 compared to $24,717 for the same period in 2018. The difference between periods is due to the funding during the quarter of a new program to test and evaluate Amerityre bike tires.

 

Sales & Marketing Expenses. Sales and marketing expenses for the quarter ended December 31, 2019 were $51,309 compared to $53,325 for the same period in 2018.

 

General & Administrative Expenses.  General and administrative expenses for the quarter ended December 31, 2019 were $172,936 compared to $163,895 for the same period in 2018. The difference between periods was due to planned higher legal costs related to the engagement of new SEC counsel, offset by lower warranty expense in the current period compared to the year earlier period.

 

Other Expense, net.  Other expense, net, for the quarter ended December 31, 2019 was $145 compared to $647 for the same period in 2018. The primary driver of this variance is lower interest expense due to the payoff of debt.

 

Net Income (Loss).  Net income for the quarter ended December 31, 2019 of $38,395 compared to net loss of $94,744 for the same period in 2018, a positive increase in net income of $133,139.

 

Six Months Ended December 31, 2019 Compared to December 31, 2018

 

Net Revenues.  Net revenues of $2,046,737 for the six-month period ended December 31, 2019, represents a 27.0% increase over net sales of $1,612,349 for the same period in 2018. These results were above our expectations and driven by increased demand for polyurethane foam tires from current customers as well as sales to new customers. We expect farm income to remain low for the remainder of fiscal year 2020 resulting in continued depressed agricultural tire sales. However, we believe the strength in the polyurethane foam tire market segment will continue for the remainder of fiscal year 2020.

 

Cost of Revenues.  Cost of revenues for the six-month period ended December 31, 2019 was $1,459,357 or 71.3% of sales compared to $1,198,277 or 74.3% of sales for the same period in 2018. This increase in Gross Margin was due to sales of higher margin products as well as stabilized raw material costs. The prospects for tariff relief for our steel wheels purchased from China are uncertain, but we do not expect tariffs to increase further in the coming year. 

 

Gross Profit.  Gross profit for the six-month period ended December 31, 2019 was $587,380 compared to $414,072 for the same period in 2018, an increase of $173,308 or 41.8% over the same period in 2018.  The December 31, 2019 gross profit reflects a 28.7% gross margin for product sales compared to a gross margin on product sales of 25.7% in 2018.

 

Research & Development Expenses (R&D).  Research and development expenses for the six-month period ended December 31, 2019 were $61,913 compared to $47,790 for the same period in 2018. The higher expenses in the fiscal year 2020 period are due to costs associated with our new bike tire evaluation and test program. The Company plans to continue to invest in R&D as a key component of our new product and business improvement initiatives.

 

 

Sales & Marketing Expenses. Sales and marketing expenses for the six-month period ended December 31, 2019 were $94,780 compared to $104,249 for the same period in 2018. The difference between periods relates to lower commissions paid as a percentage of sales during the current period, offset by higher trade show expenses, when compared to the same six-month period in 2018.

 

General & Administrative Expenses.  General and administrative expenses for the six-month period ended December 31, 2019 were $366,366 compared to $353,443 for the same period in 2018. The difference between periods related to higher anticipated legal costs related to the engagement of new SEC counsel.

 

Other Income, net.  Other income for the quarter ended December 31, 2019 was $2,977 compared to $983 for the same period in 2018. The primary driver in this variance is lower interest expense due to the payoff of debt.

 

Net Income (Loss).  Net income for the six-month period ended December 31, 2019 of $67,298 compared to a net loss of $90,427 for the same period in 2018, an increase in positive net income of $157,725.

 

Liquidity and Capital Resources

 

Cash Flows

 

The following table sets forth a summary of our cash flows for the periods below. 

 

   

Six Months ended Dec. 31,

 
   

(in 000’s)

 
   

2019

   

2018

 

Net cash (used) provided by operating activities

  $ (162

)

  $ 169  

Net cash used in investing activities

    (30

)

    (78

)

Net cash used in financing activities

    (25

)

    (9

)

Net (decrease) increase in cash during the period

  $ (217

)

  $ 82  

 

Net Cash Used by Operating Activities. In 2019, the Company decided to use a portion of its available cash to make a lump sum payment for annual insurance premiums rather than finance these expenditures over the course of the year. As a result, our prepaid assets increased in the period. During the fiscal 2020 second quarter we also saw a rise in finished product inventories in advance of our Christmas holiday shutdown, in order to be prepared for customer product shipments in early January. Net cash used in operating activities was $161,525 for the period ended December 31, 2019 compared to net cash provided by operating activities of $169,214 for the same period in 2018. 

 

Non-cash items include depreciation and amortization and stock-based compensation.  Amortization includes the amortization of our right to use asset, our facility rent. Our net income was $67,298 for the period ended December 31, 2019 compared to a net loss of $90,427 for the same period in 2018.  The net income for the period ended December 31, 2019 included non-cash expenses for depreciation and amortization of $120,762 and stock-based compensation of $19,654.  As of December 31, 2018, depreciation and amortization was $41,221 and stock-based compensation totaled $17,778.

 

Net Cash Used by Investing Activities.  Net cash used by investing activities was $30,318 for the period ended December 31, 2019 and $78,302 for the same period in 2018.  In fiscal year 2019, we invested in various manufacturing equipment items and upgraded our in-house computer infrastructure and server.

 

Net Cash Used by Financing Activities.  In line with the Company’s initiative to pay off high interest term debt with available cash, a total of $25,121 was used in financing activities for the period ended December 31, 2019 and $9,335 for the same period in 2018. The use of cash for the period ended December 31, 2019 was used to retire all of our term debt early.

 

Our principal sources of liquidity consist of cash and payments received from our customers.  As of the date of this filing, the Company is negotiating with a local bank to secure a $50,000 line of credit to provide financial flexibility. Historically, management has been reluctant to pursue financing at terms that subject the Company to the high costs of debt, or raise money through the sale of equity at prices we believe do not reflect the true value of the Company. 

 

As part of its effort to maintain adequate working capital levels, Amerityre has not declared dividends on its preferred stock since June 2016. These unpaid dividends have accrued in the amount of $25,000 per quarter since that time.

 

 

We continue to have access to a short-term receivable factoring agreement with a third party to sell our receivable invoices. This agreement enables us to sell individual customer invoices for faster cash flow to the Company. As of December 31, 2019, we have not needed to activate this financing option due to increased focus on enforcement of established collection policies and proactive communication with customers.

  

Cash Position, Outstanding Indebtedness and Future Capital Requirements

 

At February 7, 2020, our total cash balance was $414,787, none of which is restricted; accounts receivables was $343,953; and inventory, net of reserves for slow moving or obsolete inventory, and other current assets was $947,271. Our total indebtedness, specifically which management reviews for cash management, was $1,289,141 and includes $1,225,235 in accounts payable, accrued expenses and operating lease liability; $2,000 in current portion of long-term debt and $61,906 in long-term debt. As of December 31, 2019 none of our debt is term debt and is payable in association with the sales of forklift tires as described in our financial statements in this filing.

 

We continue to take actions to improve our liquidity and access to capital resources. To fully execute the annual strategic business plan discussed during our shareholder meeting in December 2019, we require more capital resources. However, management continues to maintain that an equity financing in the current market environment would be too dilutive and not in the best interests of our shareholders. We will pursue potential opportunities to secure short-term loans, long-term bank financing, revolving lines of credit with banking institutions and equity-based transactions with strategic financial firms and industry partners in our effort to improve the Company’s financial and market positions and enhance shareholder value.

 

We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. We are limiting our capital expenditures to that required to maintain current manufacturing capability or support key business initiatives identified in our strategic sales plan.  We continue to work to reduce our overall costs wherever possible. We believe that the Company’s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales. 

 

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.  In connection with the preparation of our financial statements for the period ended December 31, 2019, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.  However, to expand manufacturing and sales operations beyond the current level, additional capital may be required.

 

The Company has, on occasion, instituted initiatives to incentivize sales of slower-moving inventory through promotional pricing. These programs will continue to be selectively utilized in the upcoming quarters to monetize inventory, promote individual product lines, and improve our cash flow.

  

As of February 12, 2020, the Company has approximately 707,000 shares of common stock authorized and available for issuance. At our 2019 Annual Shareholders Meeting, we received approval from shareholders to increase the number of authorized shares of common stock to 100 million shares. We requested this approval for an increase in authorized shares to provide management the flexibility to raise capital if required. However, we have yet to receive approval from our preferred shareholder to increase the level of the authorized shares, which is required by our current preferred stock agreement.

 

Off-Balance Sheet Arrangements

 

We do not currently have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts.

 

 

Cautionary Note Regarding Forward Looking Statements

 

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding economic conditions in general and in the agricultural market, in particular, tariffs imposed by China and the US arising from the current geo-political tension between those jurisdictions, our ability to increase our authorized capital and pursue future financings, our sales prospects in light of new products, increased sales and resulting profits, continued strength of our current polyurethane foam tire market segment and liquidity. All statements other than statements of historical facts contained in this report, including statements regarding our future financial position, liquidity, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

 

These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in our 2019 Annual Report. New risk factors emerge from time-to-time and it is not possible for us to predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any risk factor, or combination of risk factors, may cause actual results to differ materially from those contained in any forward-looking statements. Except as otherwise required by applicable laws, we undertake no obligation to publicly update or revise any forward-looking statements described in this report, whether as a result of new information, future events, changed circumstances or any other reason after the date this report is filed. 

 

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive and Financial Officers, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this quarterly report to ensure the information required to be disclosed by us in reports is timely recorded, processed, summarized and reported in accordance with the SEC’s rules and forms and communicated to our management as appropriate to allow timely decisions regarding required disclosure.

 

 

 

PART II - OTHER INFORMATION

 

ITEM 1.  LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our 2019 Annual Report.

 

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.  MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5.  OTHER INFORMATION

 

None.

 

ITEM 6.  EXHIBITS

 

 

 

 

 

Incorporated by Reference

 

Filed or Furnished

Exhibit #

 

Exhibit Description

 

Form

 

Date

 

Number

 

Herewith

3.1

 

Articles of Incorporation of the Company

 

8-A12G

 

10/28/02

 

3.01

 

 

3.2

 

Certificate of Amendment to the Articles of Incorporation of the Company

 

8-A12G

 

10/28/02

 

3.01

 

 

3.3

 

Certificate of Amendment to the Articles of Incorporation

 

10-Q

 

2/14/13

 

3(i)

 

 

3.4

 

Bylaws of the Company

 

8-K

 

9/25/13

 

3.02

 

 

10.1

 

Employment Agreement between the Company and Michael Sullivan

 

8-K

 

12/20/19

 

5.02

   
                     

31.1

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

Filed

31.2

 

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

Filed

32.1

 

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

Filed

32.2

 

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

Filed

101 INS

 

XBRL Instance Document

 

 

 

 

 

 

 

 

101 SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

 

 

 

 

Filed

101 CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

 

 

 

Filed

101 DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

 

 

 

Filed

101 LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

 

 

 

Filed

101 PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

Filed

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated:  February 14, 2020

 

AMERITYRE CORPORATION

 

 

 

By:

 

 

 

/s/ Michael F. Sullivan

 

/s/ Lynda R. Keeton-Cardno

 

Michael F. Sullivan

Chief Executive Officer

(Principal Executive Officer)

 

Lynda R. Keeton-Cardno

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 

 

 

 

20